264
Views
3
CrossRef citations to date
0
Altmetric
Theme: Stroke - Review

Management of blood pressure in acute stroke

, &
Pages 911-923 | Published online: 09 Jan 2014

References

  • Marshall J, Shaw DA. The natural history of cerebrovascular disease. BMJ. 1, 1614–1617 (1959).
  • Yatsu FM, Zivin J. Hypertension in acute ischaemic stroke: not to treat. Arch. Neurol. 42, 999–1000 (1985).
  • Spence JD, Del Maestro RF. Hypertension in acute ischaemic strokes—treat. Arch. Neurol. 42, 1000–1002 (1985).
  • Ahmed N, Wahlgren NG. High initial blood pressure after acute stroke is associated with poor functional outcome. J. Intern. Med. 249, 467–473 (2001).
  • Chammorro A, Vila N, Ascaso C, Elices E, Schonwille W. Blood pressure and functional recovery in acute ischaemic stroke. Stroke 29, 1850–1853 (1998).
  • Lawes CMM, Bennett DA, Feigin VL, Rodgers A. Blood pressure and stroke and overview of published reviews. Stroke 35(3), 776–785 (2004).
  • Bonita R. Epidemiology of stroke. Lancet 339, 342–344 (1992).
  • Collins R, MacMahon S. Blood pressure, antihypertensive drug treatment and the risks of stroke and of coronary heart disease. Br. Med. Bull. 50, 272–298 (1994).
  • Rodgers A, MacMahon S, Gamble G et al. Blood pressure and risk of stroke in patients with cerebrovascular disease. The United Kingdom Transient Ischaemic Attack Collaborative Group. BMJ. 313, 147 (1996).
  • Collins R, Peto R, MacMahon S. Blood pressure, stroke and coronary heart disease 2. Short-term reductions in blood pressure: overview of randomised drug trials in their epidemiological context. Lancet 335, 827–838 (1990).
  • Eastern Stroke and Coronary Heart Disease Collaborative Research Group. Blood pressure, cholesterol, and stroke in eastern Asia. Lancet 352, 1801–1807 (1998).
  • Progress Collaborative Group. Randomised trial of a perindopril based blood pressure lowering regimen among 6105 individuals with previous stroke or transient ischaemic attack. Lancet 358, 1033–1041 (2001).
  • Neal B, MacMahon S, Chapman N. Effects of ACE inhibitors, calcium antagonists, and other blood-pressure-lowering drugs: results of prospectively designed overviews of randomised trials. Blood Pressure Lowering Treatment Trialists’ Collaboration. Lancet 356, 1955–1964 (2000).
  • Armario P, Ceresuela LM, Bello J et al. The role of blood pressure in the prognosis of acute ischaemic stroke. J. Hypertens 19(Suppl 2), s13 (2001).
  • Ahmed N, Wahlgren NG. High initial blood pressure after acute stroke is associated with poor functional outcome. J. Intern. Med. 249, 467–473 (2001).
  • Dandapani BK, Suzuki S, Kelley RE, Reyes-Iglesias Y, Duncan R. Relation between blood pressure and outcome in intracerebral hemorrhage. Stroke 26, 21–24 (1995).
  • Fiorelli M, Alpeovitch A, Argentino C et al. Prediction of long term outcome in the early hours following acute ischaemic stroke. Arch. Neurol. 95; 52, 250–255.
  • Jorgensen H, Nakayara H, Raaschou H, Olsen T. Effect of blood pressure and diabetes mellitus on stroke progression. Lancet 344, 156–159 (1994).
  • Longo-Mbenza B, Tonduangu K, Muyeno K et al. Predictors of stroke – associated mortality in Africans. Rev. Epidemiol. Sante Publique 48(1), 31–39 (2000).
  • Carlberg B, Asplund K, Hagg E. The prognostic value of admission blood pressure in patients with acute stroke. Stroke 24, 1372–1375 (1993).
  • Droller H. The outlook in hemiplegia. Geriatrics 20, 630–636 (1965).
  • Leonardi-Bee J, Bath PMW, Phillips SJ, Sandercock PAG. Blood pressure and clinical outcomes in the International Stroke Trial. Stroke 33, 1315 (2002).
  • Vemmos KN, Tsiugoulis G, Spengas K et al. U shaped relationship between mortality and admission blood pressure in patients with acute stroke. J. Intern. Med. 255, 257–265 (2004).
  • International Society of Hypertension Writing Group. International Society of Hypertension (ISH): Statement on the management of blood pressure in acute stroke. J. Hypertens. 21, 665–672 (2003).
  • Ohkubo T, Hozawa A, Nagai K et al. Prediction of stroke by ambulatory blood pressure monitoring versus screening blood pressure measurements in a general population: the Ohasama study. J. Hypertens. 18, 847–854 (2000).
  • Coats A. Reproducibility or variability of casual and ambulatory blood pressure data: implications for clinical trials. J. Hypertens. 6(Suppl. 6), S17–20 (1990).
  • Robinson TG, James MA, Youde JH, Panerai RB, Potter JF. Cardiac baroreceptor sensitivity is impaired after acute stroke. Stroke 28, 1671–1676 (1997).
  • Robinson TG, Waddington A, Ward-Close S, Taub N, Potter JF. The predictive role of 24-hour compared to casual blood pressure levels on outcome following acute stroke. Cerebrovasc. Dis. 7, 264–272 (1997).
  • Robinson TG, Potter JF. Blood pressure in acute stroke (review). Age Ageing 33, 6–12 (2004).
  • CAST: randomised placebo-controlled trial of early aspirin use in 20,000 patients with acute ischaemic stroke. CAST (Chinese Acute Stroke Trial) Collaborative Group. Lancet 349, 1641–1649 (1997).
  • International Stroke Trial Collaborative Group. The International Stroke Trial (IST): a randomised trial of aspirin, subcutaneous heparin, both, or neither among 19435 patients with acute ischaemic stroke. Lancet 349, 1569–1581 (1997).
  • Jorgensen HS, Nakayama H, Christensen HR et al. Blood pressure in acute stroke. The Copenhagen stroke study. Cerebrovasc. Dis. 13, 204–209 (2002).
  • Carlberg BO, Asplund K, Hagg E. Factors influencing admission blood pressure levels in patients with acute stroke. Stroke 22, 527–530 (1991).
  • Vemmos KN, Tsiugoulis G, Spengas K et al. U shaped relationship between mortality and admission blood pressure in patients with acute stroke. J. Intern. Med. 255, 257–265 (2004).
  • Quereshi A, Tuhrim S, Broderick J. Medical progress: spontaneous intracerebral haemorrhage. N. Engl. J. Med. 344, 1450–1460 (2001).
  • Harper G, Castleden CM, Potter JF. Factors affecting changes in blood pressure after acute stroke. Stroke 25, 1726–1729 (1994).
  • Wallace JD, Levy LL. Blood pressure after stroke. JAMA. 246, 2177–2180 (1981).
  • Brodick J, Brott T, Barsan W et al. Blood pressure during the first minutes of focal cerebral ischaemia. Ann. Emerg. Med. 22, 1438–1443 (1993).
  • Britton M, Carlsson A, de Faire U. Blood pressure course in patients with acute stroke and matched controls. Stroke 17, 861–864 (1986).
  • Aslanyan S, Fazekas F, Weir CJ, Horner S, Lees KR. Effect of blood pressure during the acute period of ischaemic stroke on stroke outcome: a tertiary analysis of the GAIN international trial. Stroke 34, 2420–2426 (2003).
  • Marcheselli S, Cavallini A, Tosi P et al. Impaired blood pressure increase in acute cardioembolic stroke. Stroke 24, 1849–1856 (2006).
  • Strandgaard S, Paulson OB. Cerebral autoregulation. Stroke 15(3), 413–416 (1984).
  • Paulson OB, Strandgaard S, Edvinsson L. Cerebral autoregulation. Cerebrovasc. Brain Metab. Rev. 2(2), 161–192 (1990).
  • Olsen TS, Larsen B, Herning M, Bech Skriver ER, Lassen NA. Blood flow and vascular reactivity in collaterally perfused brain tissue. Evidence of an ischaemic penumbra in patients with acute stroke. Stroke 14, 332–341 (1983).
  • Barker FG, Ogilvy CS. Efficacy of prophylactic nimodipine for delayed ischemic deficit after subarachnoid hemorrhage: a meta-analysis. J. Neurosurg. 84, 405–414 (1996).
  • Mayberg MR, Batjer HH, Dacey R et al. Guidelines for the management of aneurysmal subarachnoid hemorrhage: a statement for healthcare professionals from a special writing group of the Stroke Council, American Heart Association. Circulation 90, 2592–2605 (1994).
  • Rordorf G, Koroshetz WJ, Ezzeddine MA, Segal AZ, Buonanno FS. A pilot study of drug induced hypertension for treatment of acute stroke. Neurology 6, 1210–1213 (2001).
  • Rasool AHG, Rahman ARA, Choudray SR, Singh RB. Blood pressure in acute intracerebral haemorrhage. J. Hum. Hypertens 18, 187–192 (2004).
  • Yong M, Diener HC, Kaste M, Mau J. Characteristics of Blood Pressure Profiles as predictors of long-term outcome after acute ischemic stroke. Stroke 36, 2619 (2005).
  • Gariballa SE, Robinson TG, Parker SG, Castleden CM. A prospective study of primary and secondary risk factor management in stroke patients. J. R. Coll. Physicians Lond. 29, 485–487 (1995).
  • Lip GYH, Zafaris J, Farooqi IS et al. Ambulatory blood pressure monitoring in acute stroke. The West Birmingham Acute Stroke Project. Stroke 28, 31–35 (1997).
  • Myers M, Norris J, Hachinsky V, Weingert M, Sole M. Cardiac sequelae of acute stroke. Stroke 13, 838–842 (1982).
  • Myers MG, Norris JW, Hachinski VC, Sole MJ. Plasma norephinephrine in stroke. Stroke 12, 200–204 (1981).
  • Fassbender K, Schmidt R, Mobner R, Daffertshofer M, Hennerici M. Pattern of activation of the hypothalamic pituitary adrenal axis in acute stroke. Stroke 25, 1105–1108 (1994).
  • Butcher KS, Cechetto DF. Insular lesion evokes autonomic effects of stroke in normotensive and hypertensive rats. Stroke 26(3), 459–465 (1995).
  • Arboix A, Roig H, Rossich R, Martinez EM, Garcia-Eroles L. Differences between hypertensive and non-hypertensive ischemic stroke. Eur. J. Neurol. 11, 687–692 (2004).
  • Carlberg B, Asplund K, Hagg E. The prognostic value of admission blood pressure in patients with acute stroke. Stroke 24, 1372–1375 (1993).
  • Pickering TG, James GD, Body C et al. How common is white coat hypertension? JAMA. 259, 225–228 (1988).
  • Nadav L, Gur AY, Korczyn AD, Bornstein NM. Stroke in hospitalized patients: are there special risk factors? Cerebrovas. Dis. 13, 127–131 (2002).
  • Fortherby MD, Potter JF, Panayiotou B, Harper G. Blood pressure changes after stroke: abolishing the white coat effect. Stroke 24, 1422–1423 (1993).
  • Langhorne P, Stott DJ, Robertson L et al. Medical complications after stroke: a multicenter study. Stroke 31, 1223–1229 (2000).
  • Yatsu FM, Zivin J. Hypertension in acute ischaemic stroke: not to treat. Arch. Neurol. 42, 999–1000 (1985).
  • Spence JD, Del Maestro RF. Hypertension in acute ischaemic strokes—treat. Arch. Neurol. 42, 1000–1002 (1985).
  • Marshall J, Shaw DA. The natural history of cerebrovascular disease. BMJ. 1, 1614–1617 (1959).
  • Jorgensen H, Nakayara H, Raaschou H, Olsen T. Effect of blood pressure and diabetes mellitus on stroke progression. Lancet 344, 156–159 (1994).
  • Chammorro A, Vila N, Ascaso C, Elices E, Schonwille W. Blood pressure and functional recovery in acute ischaemic stroke. Stroke 29, 1850–1853 (1998).
  • Longo-Mbenza B, Tonduangu K, Muyeno K et al. Predictors of stroke – associated mortality in Africans. Rev. Epidemiol. Sante. Publique 48(1), 31–39 (2000).
  • Fiorelli M, Alpeovitch A, Argentino C et al. Prediction of long-term outcome in the early hours following acute ischaemic stroke. Arch. Neurol. 95; 52, 250–255 (1995).
  • Droller H. The outlook in hemiplegia. Geriatrics 20, 630–636 (1965).
  • Wilmot M, Leonardi-Bee J, Bath PMW. High blood pressure in acute stroke and subsequent outcome: a systematic review. Hypertens 43, 18–24 (2004).
  • Weaver CS, Leonardi-Bee J, Bath-Hextall FJ, Bath PM. Sample size calculations in acute stroke trials: a systematic review of their reporting, characteristics, and relationship with outcome. Stroke 35(5), 1216–1224 (2004).
  • Ntaios G, Bath P, Michel P. Blood pressure treatment in acute ischaemic stroke: a review of studies and recommendations. Curr. Opin. Neurol. 23, 46–52 (2010).
  • Semplicini A, Maresca A, Boscolo G et al. Hypertension in acute ischemic stroke: a compensatory mechanism or an additional damaging factor? Arch. Intern. Med. 163(2), 211–216 (2003).
  • Bath FJ, Bath PMW. What is the correct management of blood pressure in acute stroke? The blood pressure in acute stroke collaboration. Cerebrovasc. Dis. 7, 205–213 (1997).
  • Vemmos KN, Spengos K, Tsivgoulis G et al. Factors influencing acute blood pressure values in stroke subtypes. J. Hum. Hypertens. 18(4), 253–259 (2004).
  • Gilligan AK, Markus R, Read S et al.; Australian Streptokinase Trial Investigators. Baseline blood pressure but not early computed tomography changes predicts major hemorrhage after streptokinase in acute ischemic stroke. Stroke 33(9), 2236–2242 (2002).
  • Bowes HP, Ziuin JA, Thomas GR, Thibodeaux H, Fagan SC. Acute hypertension but not thrombolysis increases incidence and severity of hemorrhagic transformation following experimental stroke in rabbits. Exp. Neurol. 141, 40–46.
  • Sako Y, Choki J, Waki R et al. Hemorrhagic infarct induced by arterial hypertension in cat brain following MCA occlusion. Stroke 21, 585–595 (1990).
  • Aslanyan S, Weir CJ, Diener HC, Kaste M, Lees KR; GAIN International Steering Committee and Investigators. Pneumonia and urinary tract infection after acute ischaemic stroke: a tertiary analysis of the GAIN International trial. Eur. J. Neurol. 11(1), 49–53 (2004).
  • Lisk Dr, Grotta JC, Lamki LM et al. Should hypertension be treated after stroke? A randomised controlled trial using SPECT. Arch. Neurol. 50, 855–862 (1993).
  • Schrader J, Luders S, Kulschewski A et al. Evaluation of Candesartan Cilextil therapy in stroke survivors. Stroke 34, 1699–1703 (2003).
  • Sandset EC, Bath PMW, Boysen G et al.; on behalf of the SCAST study group. The angiotensin-receptor blocker candesartan for treatments of acute stroke (SCAST): a randomized, placebo-controlled, double-blind trial. Lancet 377, 741–750 (2011).
  • Geeganage CM, Bath PMW. Relationship between therapeutic changes in blood pressure and outcomes in acute stroke: a meta-regression. Hypertension 54, 775–781 (2009).
  • Blood Pressure in Acute Stroke Collaboration (BASC). Interventions for deliberately altering blood pressure in acute stroke (Cochrane Systematic Review). Cochrane Database Syst. Rev. 2 (2006).
  • Wise G, Sutter R, Burkholder J. The treatment of brain ischaemia with vasopressor drugs. Stroke 3, 135 (1972).
  • Wise G. Vasopressor-drug therapy for complications of cerebral arteriography. N. Engl. J. Med. 282, 610–612 (1970).
  • Mistri AK, Robinson TG, Potter JF. Pressor therapy in acute ischaemic stroke: a systematic review. Stroke 37, 1565–1571 (2006).
  • Rordorf G, Cramer SC, Efird JT et al. Pharmacological elevation of blood pressure in acute stroke clinical effects and safety. Stroke 28, 2133–2138 (1997).
  • Potter JF, Robinson TG, Ford GA et al. Controlling hypertension and hypotension immediately post-stroke (CHHIPS): a randomized, placebo-controlled, double-blind pilot trial. Lancet Neurol. 8, 48–56 (2009).
  • Robinson TG, Potter JF, Ford GA et al.; on behalf of the COSSACS Investigators. Effects of antihypertensive treatment after acute stroke in the Continue Or Stop post-Stroke Antihypertensives Collaborative Study (COSSACS): a prospective, randomized, open, blinded-endpoint trial. Lancet Neurol. 9, 767–775 (2010).
  • Philippon J, Grob R, Dagreou F et al. Prevention of vasospasm in subarachnoid haemorrhage. A controlled study with nimodipine. Acta Neurochir. 82, 110–114 (1986).
  • Germano IM, Bartkowski HM, Cassel ME, Pitts LH. The therapeutic value of nimodipine in experimental focal cerebral ischemia. Neurological outcome and histopathological findings. J. Neurosurg. 67, 81–87 (1987).
  • Horn J, Limburg M. Calcium antagonists for acute ischaemic stroke (Cochrane Systematic Review). Cochrane Database Syst. Rev. 2 (2006).
  • Niaz A, Nasman P, Wahlgren NG. Effect of intravenous nimodipine on blood pressure and outcome after acute stroke. Stroke 31, 1250–1255 (2000).
  • Franke CL, Palm R, Dalby M et al. Flunarizine in stroke treatment (FIST): a double blind placebo controlled trial in Scandinavia and the Netherlands. Acta Neurol. Scand. 93(1), 56–60 (1996).
  • Hakim AM, Evans AC, Berger L et al. The effect of nimodipine on the evolution of human cerebral infarction studied by PET. J. Cerebral Blood Flow Metab. 9(4), 523–534 (1989).
  • Standefer M, Little JR. Improved neurological outcome in experimental focal cerebral ischemia treated with propranolol. Neurosurgery 18(2), 136–140 (1986).
  • Savitz SI, Erhardt JA, Anthony JV et al. The novel beta-blocker, carvedilol, provides neuroprotection in transient focal stroke. J. Cerebral Blood Flow Metab. 20(8), 1197–1204 (2000).
  • Barer DH, Cruikshank JM, Ebrahim SB, Mitchell JR. Low dose beta blockade in acute stroke (“BEST” trial): an evaluation. BMJ. 296, 737–741 (1988).
  • The National Institutes of Neurological Disorders and Stroke rt-PA Stroke Study Group. Tissue plasminogen activator for acute ischemic stroke. N. Engl. J. Med. 333, 1581–1587 (1995).
  • Brott T, Lu M, Kothari R et al. Hypertension and its treatment in the NINDS rt-PA stroke trial. Stroke 29, 1504–1509 (1998).
  • Patel RV, Kertland HR, Jahns BE et al. Labetalol: response and safety in critically ill hemorrhagic stroke patients. Ann. Pharm. 27, 180–181 (1993).
  • Eames PJ, Robinson TG, Panerai RB, Potter JF. Bendrofluazide fails to reduce elevated blood pressure levels in the immediate post-stroke period. Cerebrovasc. Dis. 19, 253–259 (2005).
  • Bath PMW, Pathansali R, Iddenden R, Bath FJ. The effect of transdermal glyceryl trinitrate, a nitric oxide donor, on blood pressure and platelet function in acute stroke. Cerebrovasc. Dis. 11, 265–272 (2001).
  • Wilmot M, Ghadami A, Whysall B et al. Transdermal glyceryl trinitrate lowers blood pressure and maintains cerebral blood flow in recent stroke. Hypertension 47, 1209–1215 (2006).
  • Cottrell JE, Patel K, Turndorf H, Ransohoff J. Intracranial pressure changes induced by sodium nitroprusside in patients with intracranial mass lesions. J. Neurosurg. 48, 329–331 (1978).
  • Inada Y, Wada T, Sanada T et al. Protective effects of candesartan cilexitil against stroke, kidney dysfunction and cardiac hypertrophy in stroke prone spontaneously hypertensive rats. Clin. Exp. Hypertens. 19, 1079–1099 (1997).
  • Walters M, Muir S, Shah I, Lees KR. Effect of perindopril on cerebral vasomotor reactivity in patients with lacunar infarction. Stroke 35, 1899 (2004).
  • Dyker AG, Grosset DG, Lees KR. Perindopril reduces blood pressure but not cerebral blood flow in patients with recent cerebral ischaemic stroke. Stroke 28, 580–583 (1997).
  • Walters MR, Dyker AG, Lees KR. The effect of perindopril on cerebral and renal perfusion in stroke patients with carotid disease. Cerebrovasc. Dis. 10(Suppl. 2), 75 (2000).
  • Scrader J, Rothemeyer M, Luders S, Kollman K. Hypertension and stroke - the rationale behind the ACCESS trial. Basic Res. Cardiol. 93(Suppl. 2), 69–78 (1999).
  • Dahlof B, Devereux RB, Kjeldsen SE, Julius S, Beevers G, de Faire U et al.; for the LIFE study group. Cardiovascular morbidity and mortality in the Losartan Intervention for Endpoint reduction study (LIFE): a randomised trial against atenolol. Lancet 359, 995–1003 (2002).
  • Nazir FS, Overell JR, Bolster A, Hilditch TE, Reid JL, Lees KR. The effect of losartan on global and focal cerebral perfusion and on renal function in hypertensives in mild early ischaemic stroke. J. Hypertens. 22, 989–995 (2004).
  • Schrader J, Luders S, Kulschewski A et al. Morbidity and mortality after stroke, eprosartan compared with nitrendipine for secondary prevention: principle results of a prospective randomized controlled study (MOSES). Stroke 36(6), 1218–1226 (2005).
  • Yusuf C, Diener HC, Sacco RL et al. Telmisartan to prevent recurrent stroke and cardiovascular events. N. Engl. J. Med. 359(12), 1225–1237 (2008).
  • Fogelholm R, Avikainen S, Murros K. Prognostic value and determinants of first-day mean arterial pressure in spontaneous supratentorial intracerebral hemorrhage. Stroke 28(7), 1396–1400 (1997).
  • Powers WJ, Zazulia AR, Videen TO et al. Autoregulation of cerebral blood flow surrounding acute (6 to 22 hours) intracerebral hemorrhage. Neurology 57(1), 18–24 (2001).
  • ATACH Investigators. Antihypertensive treatment of acute cerebral hemorrhage. Crit. Care Med. 38, 637–648 (2010).
  • Butcher KS, Jeerakathil T, Hill M et al. The Intracerebral haemorrhage acutely decreasing arterial pressure trial (ICH ADAPT): Final results. Stroke 44, A113 (2013).
  • Anderson CS, Huang Y, Wang JG et al.; for the INTERACT Investigators. Intensive blood pressure reduction in acute cerebral haemorrhage trial (INTERACT): a randomized pilot trial. Lancet Neurol. 7, 391–399 (2008).
  • Anderson CS, Heeley E, Huang Y et al. Rapid blood-pressure lowering in patients with acute intracerebral hemorrhage. N. Engl. J. Med. doi:10.1056/NEJMoa1214609 (2013).
  • Bath PMW, Weaver C, Iddenden R. A trial of blood pressure reduction in stroke age. Ageing 29(6), 554–555 (2001).
  • Kanji S, Corman C, Douen AG. Blood pressure management in acute stroke: comparison of current guidelines with prescribing patterns. Can. J. Neurol. Sci. 29, 125–131 (2002).
  • Adams HP, Adams RJ, Brott T et al.; Stroke Council of the American Stroke Association. Guidelines for the early management of patients with ischemic stroke: A scientific statement from the Stroke Council of the American Stroke Association. Stroke 34(4), 1056–1083 (2003).
  • Quinn TJ, Reid JLR. Hypertension in acute stroke. In: European Society of Hypertension, Manual of Hypertension. Chapter 44. Informa Healthcare, London, UK (2007).

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.